Skip to content


In accordance with Section 287(a) of Title 35 of the United States Code, notice is hereby given of the US patent covering TARPEYO® (budesonide) delayed release capsules.

TARPEYO® (budesonide) delayed release capsules is covered by US patent 8,491,932.

The patent information displayed on this page is believed to be accurate as of the most recent update of the page but should not be considered exhaustive. In particular, omission of a particular patent from this page is not an admission or representation that that patent does not cover TARPEYO® (budesonide), delayed release capsules, and/or one or more of its components.